Catalina Barcelo
Geneve, GE, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Safety, tolerability, pharmacokinetics, and antimalarial activity of MMV533: a phase 1a first-in-human, randomised, ascending dose and food effect study, and a phase 1b Plasmodium falciparum volunteer infection study.
Journal: The Lancet. Infectious diseases
Published: August 13, 2024
Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection study.
Journal: The Lancet. Infectious diseases
Published: July 13, 2021
Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183.
Journal: Nature communications
Published: May 17, 2021
Impact of Genetic and Nongenetic Factors on Body Mass Index and Waist-Hip Ratio Change in HIV-Infected Individuals Initiating Antiretroviral Therapy.
Journal: Open forum infectious diseases
Published: September 24, 2019
Contribution of Genetic Background and Data Collection on Adverse Events of Anti-human Immunodeficiency Virus (HIV) Drugs (D:A:D) Clinical Risk Score to Chronic Kidney Disease in Swiss HIV-infected Persons With Normal Baseline Estimated Glomerular Filtration Rate.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 18, 2019
Population pharmacokinetics of dolutegravir: influence of drug-drug interactions in a real-life setting.
Journal: The Journal of antimicrobial chemotherapy
Published: November 15, 2018
Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals.
Journal: Antimicrobial agents and chemotherapy
Published: May 09, 2016
Contribution of Genetic Background and Clinical Risk Factors to Low-Trauma Fractures in Human Immunodeficiency Virus (HIV)-Positive Persons: The Swiss HIV Cohort Study.
Journal: Open forum infectious diseases
Published: April 18, 2016
Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals.
Journal: The Journal of antimicrobial chemotherapy
Published: October 13, 2015
In Vivo Profiling and Distribution of Known and Novel Phase I and Phase II Metabolites of Efavirenz in Plasma, Urine, and Cerebrospinal Fluid.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: June 05, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026